Insulin-responsive glucose transporter expression in renal microvessels and glomeruli  by Brosius, Frank C. et al.
Kidney International, Vol. 42 (1992), pp. 1086—1092
Insulin-responsive glucose transporter expression in renal
microvessels and glomeruli
FRANK C. BRoslus III, Josii P. BRIGGS, Ro G. MARCUS, MARIO BARAC-NIETO,
and MAUREEN J. CHARRON
Division of Nephrology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, and Departments of
Pediatrics and of Biochemistry, Albert Einstein College of Medicine, Bronx, New York, USA
Insulin.responsive glucose transporter expression in renal microvessels
and glomeruli. The insulin-responsive glucose transporter (GLUT4) is
expressed at high levels in fat and skeletal muscle, which account for
the majority of insulin-stimulated glucose uptake. However, GLUT4 is
also expressed at lower levels in kidney and several other tissues. We
have used a variety of protein and mRNA detection techniques to
determine the sites of renal GLUT4 expression. Indirect immunofluo-
rescence experiments with two specific anti-peptide antisera detected
GLUT4 in the smooth muscle cells of the rat renal microvasculature, in
renal glomerulus, and in cultured glomerular mesangial and epithelial
cells. PCR amplification of cDNA derived from microdissected renal
glomeruli, microvessels and tubules corroborated this distribution of
GLUT4, and Northern blotting demonstrated GLUT4 mRNA in cul-
tured glomerular mesangial cells. Both the immunofluorescence and
PCR data suggested that GLUT4 is most highly expressed in renal
microvessels. Our results show that certain renal cells, such as renal
microvascular smooth muscle cells, express the insulin-responsive
glucose transporter and therefore may demonstrate altered glucose
uptake and metabolism in diabetes mellitus.
The uptake of glucose by most cells is accomplished via a
stereo-specific facilitated diffusion transport process. At
present, the primary amino acid sequences of five related but
distinct glucose transporters have been elucidated by cloning of
their cDNAs [I—Il]. All of these transporters share substantial
sequence identity and all are predicted to be plasma membrane
proteins with 12 membrane-spanning domains [I]. One of these
transporters, the insulin-responsive glucose transporter, or
GLUT4, is present at high levels in fat and in skeletal and
cardiac muscle. Insulin stimulates glucose uptake in these
tissues primarily by inducing the translocation of GLUT4 from
an intracellular microsomal compartment to the plasma mem-
brane [12—17]. In diabetes mellitus, the plasma membrane
expression of GLUT4 in fat and skeletal muscle is severely
depressed [18—21], thus restricting glucose uptake and leading
to hyperglycemia. GLUT4 mRNA is expressed at high levels
only in fat and striated muscle. However, small amounts of
GLUT4 mRNA have been detected in a few other tissues,
including kidney [7]. The present studies were undertaken to
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examine the expression of GLUT4 in kidney using protein and
RNA detection techniques.
Methods
Antibodies
Antisera against peptides corresponding to the carboxy ter-
minus and the amino terminus of the rat GLUT4 amino acid
sequence were generated. These regions differ substantially in
sequence from the corresponding regions of the other cloned
GLUTs. One peptide consisted of the 16 carboxy-terminal
(494-509) amino acids of GLUT4 while the other peptide was
comprised of the 16 amino-terminal residues (1-16) of the
protein. Both peptides were coupled to keyhole limpet hemo-
cyanin via a cysteine residue with sulfosuccinimidyl 4-(N-
maleimide-methyl)-cyclohexane- I -carboxylate [22], were emul-
sified in complete Freund's adjuvant, and were injected
subcutaneously into separate rabbits. After subsequent intrave-
nous injections with the respective peptides in phosphate buff-
ered saline (PBS; 137 mi NaCI, 10 m sodium phosphate, pH
7.4), sera was obtained from each rabbit.
Immunoblotting
Cortical sections were prepared from kidneys removed from
150 to 200 g Sprague-Dawley rats. The renal cortical tissue was
minced and suspended in lysis buffer [1% Triton X, 0.1%
sodium dodecyl sulfate (SDS), 5 mt N-ethylmaleimide, 2 mM
ethylenediaminetetraacetate, and 2 mM phenylmethylsulfo-
nylfluoride} and sonicated for 90 seconds. The samples were
then spun at 13,000 x g in a microfuge, and the supernatants
reserved and tested for protein content by bicinchoninic acid
assay (Pierce). Cellular lysates were suspended in Laemmli
sample buffer, separated on 10% SDS-PAGE gels and were
blotted conventionally onto nitrocellulose filters. Filters were
blocked with 1 to 5% nonfat dry milk in TBS (20 mrvt Tris-HCI,
pH 7.5; 150 mM NaCl; 1% Nonidet-P-40), probed with the
carboxy-terminal antiserum (dilution = 1:1000) or amino-termi-
nal antiserum (dilution 1:50), washed in TBS, blocked again,
incubated with '251-donkey anti-rabbit IgG (Amersham),
washed in TBS, and exposed to film.
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experiments were performed identically as above except that
the GLUT4 antiserum was incubated with 100 sg/ml of the
appropriate immunizing peptide for 15 minutes at room temper-
ature prior to incubation with the kidney sections or glomerular
cells.
RNA preparation and Northern analysis
Fig. 1. linmunoblots of300 ,.g of kidney cortex lysate. The blot on the
left (C-term) was incubated either with a 1: 1000 dilution of the carboxy-
terminal serum (+) or with the same dilution of the specific pre-immune
serum (—). The blot on the right (N-term) was incubated with a 1:50
dilution of either the amino-terminal antiserum (-I-) or the specific
preimmune serum (—). Both antisera detect a ca. 45 kd protein. The
positions of molecular weight markers for each blot are indicated.
Immunocytochemistry
Male Sprague-Dawley rats (150 to 200 g) were sacrificed with
intraperitoneal injection of pentobarbital. Some kidneys were
perfused with PBS before freezing, but most were removed
without perfusion and snap-frozen in liquid nitrogen. Frozen
sections (ca. 4 s) were prepared on a cryomicrotome, placed on
0.1% poly-L-lysine coated glass slides and kept at —20°C until
use. Alternatively, renal glomeruli were harvested by sequen-
tial sieving of minced renal cortex through 150 t and 63 j.tmesh
[23]. An aliquot of the sieved glomeruli was then assessed
microscopically for purity. The glomeruli were then incubated
in modilied Waymouth's medium with 17% fetal call serum [241
for 10 days. This resulted in an outgrowth of cells with at least
two morphologies. Pure cultures of glomerular mesangial cells
were obtained by continuing culture of glomerular outgrowth
for three weeks, splitting the cells 1:3 and passaging the cells at
least three more times until morphological and immunohisto-
chemical uniformity was achieved.
Tissue sections were fixed for two minutes in acetone,
whereas glomerular cellular outgrowth and mesangial cell slides
were fixed for two minutes in methanol. All were then washed
in PBS, blocked with 10% goat serum and 1% bovine serum
albumin (fraction V) in PBS, incubated with the primary
GLUT4 antiserum (1:50 for the amino-terminal and 1:200 for
the carboxy-terminal antisera) or preimmune serum in blocking
solution for one hour, washed with PBS three times, incubated
with fluoresceinated-goat-anti-rabbit IgG at a concentration of
1:200 for 30 minutes in blocking solution (the secondary anti-
body was precleared with 10% rat serum), then washed in PBS
three times, and used for microscopy. Peptide competition
Kidneys were removed from freshly sacrificed Sprague-
Dawley rats (150 to 200 g) and were either snap-frozen in liquid
nitrogen or used immediately for RNA preparation. Kidneys
and cultured mesangial cells were disrupted in 4 M guanidinium
thoiocyanate, 25 m sodium citrate (pH 7.0), 0.5% sarcosyl, 0.1
M f3-mercaptoethanol, and RNA was purified by the acid-phenol
method [25]. The RNA was resuspended in purified water
treated with 0.1% diethylpyrocarbonate. Poly (Al RNA was
isolated on an oligo(dT) cellulose column using 0.5 M LiC1
binding solution [26]. For Northern blot analyses, RNA was
electrophoresed in 6% formaldehyde, 1.0% agarose gels and
then transferred with 10 x SSC (1 x SSC = 150 mM NaCI, 15
m sodium citrate, pH 7.0) to nylon membranes. After fixation,
the membranes were prehybridized then hybridized in solutions
containing 50% formamide, 5 x SSC, 5 x Denhardt's solution
(1 x Denhardt's = 0.02% each of Ficoll, bovine serum albumin,
and polyvinylpyrrolidione), 0.1% SDS, and 100 g/ml dena-
tured sheared salmon sperm DNA. Full-length, uniformly 32P-
labeled antisense RNA probes were in vitro-transcribed from
200 ng of recombinant GLUT4 plasmid vector with T7 RNA
polymerase and added to the hybridization solution at 1 to 2 x
106 cpm/ml and hybridized at 60°C overnight. The blots were
washed four times for fifteen minutes in 0.1 x SSC, 0.1% SDS
at 65°C. These conditions assure detection of GLUT4 with no
significant cross-hybridization to other glucose transporter
mRNA's [7],.
Micro-RNA preparation, cDNA synthesis and polymerase
chain reaction ampl(fication
A rat kidney was removed immediately after euthanasia, and
coronal sections approximately 2 mm in thickness were ob-
tained and placed in oxygenated Dulbecco's modified Eagle
medium with 1% (wt/vol) collagenase A (Boehringer-Mann-
heim) at 37°C for 15 minutes. Dissection was performed at 4°C
with darkfield illumination at 75 to 150 x magnification. Various
nephron segments (glomerulus, interlobular artery, interlobular
artery plus afferent arteriole, proximal convoluted tubule) were
isolated. All specimens were obtained at one setting from the
same kidney preparation and subsequent steps were performed
concurrently with the same reagents. The specimens were
transferred to 100 p.l of 4 M guanidinium thiocyanate and frozen
in liquid nitrogen. A sample which contained no tissue speci-
men was processed identically to the other samples and used as
a negative control (see below). RNA was isolated with micro-
modifications [27] of standard CsCl cushion methods [28].
Specimens were sonicated and layered on a 5.7 M CsCl cushion
together with 20 g of E. coli ribosomal RNA as a carrier. They
were centrifuged using a TL-lOO ultracentrifuge at 300,000 X g
for two hours. RNA was then dissolved, and ethanol precip-
itated. Each RNA microsample was subjected to first strand
eDNA synthesis using oligo(dT) as a primer. The sample was
added to 500 ng of oligo(dT) and heated to 65°C and cooled to
C-term N-term
II
+ +
97—
46— It S
—43
S
—29
30—
1088 Brosius et a!: Renal expression of GLUT4
Fig. 2. Indirect immunofluorescence of a rat
kidney frozen section incubated with the
carboxy-terminal antipeptide GLUT4
antiserum. GLUT4 immunofluorescence is
present in cells in the glomerulus (glom), and
in vascular smooth muscle cells of the afferent
arteriole (AA) and the interlobular artery (IL).
Other sections (not shown) were incubated
with specific preimmune serum and were
negative. Magnification = 911 x.
Fig. 3. Indirect immunofluorescence with the
carboxy-termina! GLUT4 antiserum. A.
Vascular pole of a rat glomerulus (glom) and
the distal portion of its afferent arteriole,
including juxtaglomerular cells (JGC). B.
Midportion of a rat afferent arteriole.
Magnification = 3367 x.
allow annealing. The annealed sample was combined with 0.2
mM dNTPs and 25 units of Superscript MMLV reverse tran-
scriptase in a buffer recommended by the supplier (Bethesda
Research Laboratories). This final sample was incubated at
42°C for one hour. Fractions were removed from this sample
and used as templates for PCR. These fractions were placed in a
buffer solution containing S pmoles of each specific GLUT4
primer (5' primer = ATTGGATCCAGCGGGTTCCATCCAT-
GAGT, corresponding to nucleotides 1124-1143 with sequence
encoding a BamH! site and three nonsense bases at its S'end; 3'
primer = GTCGAATTCGGTTTCACCTCCTGCTCTAA,
which is the reverse complement of nucleotides 1468-1487, with
sequence encoding an EcoRI site and three nonsense bases at
its 5' end). Also included in the PCR solution were 0.2 mM
dNTPs, 1 pCi of a[32P] dCTP, 8 mrt dithiothreitol, and 2.5 units
of Taq polymerase in a final volume of 50 d [301. Thirty PCR
cycles were performed with an annealing temperature of 54°C
( [(G + C) X 4] + [(A + T) x 2] — 6°C, calculated only for
nucleotides which annealed to the target cDNA). The PCR
samples were then precipitated with linear acrylamide, resus-
pended in 10 d of TE (10 mtvi Tris-HCI, 1 mrt EDTA, pH 7.5),
and then loaded and separated on 5% acrylamide, I x TBE gels
(1 x TBE = 45 ms'i Tris-borate, 1 mrvt EDTA), A portion of the
PCR product from rat kidney was digested with the restriction
endonuclease Sac! under conditions recommended by the sup-
plier (New England Biolabs), and the digest products were
loaded and separated on a 5% acrylamide gel. Gels were dried
and exposed to Xomat-AR film at —80°C with an intensifying
screen.
Results
In immunoblot experiments, a GLUT4 polypeptide was de-
tected in rat kidney cortex preparations by both the carhoxy-
and amino-terminal antisera (Fig. 1). These data confirm the
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Fig. 4. Indirect imniunofluorescence of
cultured rat glomerular mesangial cells. (A)
Cells incubated with the carboxy-terminal
GLUT4 antiserum. (B) Cells incubated with
the carboxy-terminal GLUT4 antiserum after
preincubation of the antiserum with the
carboxy-terminal immunizing peptide at a
concentration of 100 zg/ml. The peptide
competed away the GLUT4
immunofluorescence. Magnification = 639 x.
presence of GLIJT4 in rat kidney. The apparent molecular
weight of GLUT4 in kidney is approximately 45 kd, as it is in fat
and muscle.
Renal immunocytochemical localization showed detection of
renal afferent microvascular and glomerular antigens by each of
the GLUT4 antisera (Figs. 2 and 3). The intensity of GLUT4
immunofluorescence was greater in the afferent microvascula-
ture than in the glomeruli, and appeared to be confined to the
smooth muscle cells (Figs. 2 and 3). Background fluorescence
was present to some degree in frozen section preparations of
vascular tissues. However, the incubation and blocking condi-
tions described above were found to markedly attenuate this
background fluorescence in large vessels and virtually eliminate
it in smaller vessels. GLUT4 was also detected by each
antiserum in two cell types in primary glomerular outgrowth
(not shown) as well as in homogenous cultures of rat glomerular
mesangial cells (Fig. 4). Based on morphology, the two cell
types in primary glomerular culture appeared to be epithelial
cells and mesangial cells. Homogenous cultures of mesangial
cells were verified by immunohistochemical properties (positive
for smooth muscle actin, desmin and vimentin; negative for
cytokeratin; data not shown). In glomeruli, microvasculature
and cultured mesangial cells, the positive GLUT4 immunoflu-
orescence signal was eliminated or greatly depressed by prein-
cubation of each antiserum with the appropriate immunizing
peptide (Fig. 4). Occasionally, a positive immunofluorescent
signal was found in cortica collecting tubule cells with either of
the two GLUT4 antibodies. This signal was not competed
away, however, by preincubation with the immunizing peptide,
and therefore was considered to be nonspecific.
A 2.8 kb GLUT4 mRNA was detected in poly (A') kidney
RNA and in RNA from cultured mesangial cells in Northern
blot experiments (Fig. 5). This transcript was identical in
mobility to the GLUT4 transcript of rat skeletal muscle and fat.
GLUT4 mRNA was also detected in total mesangial cell RNA
(not shown), but due to strong hybridization between the 28S
ribosomal RNA and the full-length GLUT4 antisense cRNA
probe, poly (A') RNA was used to establish the absence of an
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Fig. 5. Northern Not of 5 jsg of poly A) RNA from rat mesangial
cells (MC) and 16 jxg of poly (A) RNA from total rat kidney (TK). The
blot was probed with a GLUT4 antisense cRNA probe under high
stringency conditions and exposed to film for 16 hours. A 2.8 kb
GLUT4 transcript is present in both lanes. A smaller transcript (Ca. 1
kb) is also present in both lanes.
alternate GLUT4 transcript of mobility similar to ribosomal
RNA. A smaller transcript (approx. I kb) was also detected in
both kidney and mesangial cells. GLUT4 cDNA was also
amplified by the polymerase chain reaction (PCR) from cDNA
derived from the RNA of microdissected afferent microvascular
samples, glomeruli, and proximal tubules (Fig. 6). The amount
of the 364 bp GLUT4 PCR product derived from 2 mm of
afferent microvasculature (interlobular artery plus afferent ar-
teriole) was roughly equivalent to that derived from 21 glomer-
uli and was greater than that derived from 10 mm of proximal
tubule (Fig. 6). Qualitatively consistent PCR results were
obtained with cDNA from four separate preparations of micro-
vascular, glomerular and proximal tubular RNA (not shown).
The specificity of the PCR products was confirmed with restric-
tion endonuclease (Sad) digestion of the GLUT4 PCR prod-
ucts, which produced two fragments of approximately 100 and
260 base pairs (data not shown; this restrictioh site is absent in
the corresponding sequence of the four other cloned rat glucose
transporters). Although strict quantitative PCR methods were
not employed, it is likely that relative GLUT4 mRNA expres-
sion follows the pattern suggested by the PCR experiments.
These data correspond well with the immunocytochemical
findings, which together suggest that GLUT4 mRNA and pro-
tein are most highly expressed in the vascular smooth muscle
cells of the afferent microvasculature, followed by glomerular
mesangial (and perhaps epithelial cells), with very little expres-
sion in proximal tubular or other tubular cells.
Discussion
The present studies demonstrate that the insulin-responsive
glucose transporter, GLUT4, is expressed in the glomerulus
and in the small vessels of the kidney, with especially high
levels of expression in preglomerular vascular smooth muscle
cells. These findings suggest that conditions, such as diabetes
mellitus, which lead to depressed GLUT4 expression in fat and
Fig. 6. PCR amplification of cDNA derived from 10 mm of proximal
convoluted tubule (PCT), 21 glomeruli (Gloms), and 2 and 10 mm of
afferent arteriole plus interlobular artery (Art). The 364 bp product is
the amplified GLUT4 cDNA. The 800 bp product is amplified genomic
DNA which is a variable and inconsistent contaminant of the original
RNA preparations. The PCR reactions were loaded and electro-
phoresed in a 5% acrylamide gel which was dried and exposed to film
for 16 hours.
skeletal muscle, may also result in decreased renal microvas-
cular smooth muscle cell GLUT4 levels. Decreased plasma
membrane GLUT4 expression would be expected to lead to
diminished glucose uptake by these cells, as is found in other
insulin-responsive tissues [18—211. Indeed, previous functional
investigations have shown that diabetes, fasting, and insulin
administration alter vascular glucose uptake in a similar way to
that of skeletal muscle and fat. Studies by Dahlkvist, Arnqvist,
and Norrby have demonstrated that arterial smooth muscle
glucose uptake and utilization are diminished in diabetes, and
that chronic insulin treatment can reverse these changes [29].
Furthermore, fasting, another condition characterized by low
insulin levels, causes decreased glucose uptake and utilization
in arterial smooth muscle [301, as it does in fat [31]. As in
isolated fat cells, insulin stimulates glucose uptake in cultured
vascular smooth muscle cells [32] and finally, glomerular
mesangial cells have also been shown to demonstrate enhanced
glucose uptake with insulin stimulation [33].
Studies of the regulation of GLUT4 expression in the renal
microvasculature are likely to have important functional impli-
cations. Several properties make it likely that the rate of
glucose metabolism in vascular smooth muscle cells is propor-
tional to the number of plasma membrane glucose transporters.
First, intracellular glucose concentration is very low and glu-
cose transport appears to be the rate-limiting step in glucose
metabolism in these cells [34]. Second, glucose uptake in
vascular smooth muscle cells is probably more dependent on
the number of plasma membrane transporters than on the
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concentration of extracellular glucose. This conclusion is sup-
ported by functional studies demonstrating that glucose uptake
and metabolism in vascular preparations are only slightly stim-
ulated by increasing extracellular glucose above normal levels
[35]. Most facilitative glucose transporters, including GLUT4,
have relatively high affinities for glucose (Km = <Ito 5 mM),
such that their activity is near maximal at physiologic levels of
extracellular glucose [36]. These relationships suggest that
factors or conditions which affect the number of glucose trans-
porters on these cells could alter intracellular glucose metabo-
lism and thus affect cell function. For example, work in our
laboratories has demonstrated the presence of ATP-sensitive
potassium channels on the vascular smooth muscle cells of the
afferent microvasculature, which appear to be sensitive to
glucose uptake and metabolism [371. These channels represent
a mechanism by which vascular smooth muscle contractility
may be influenced by changes in the number of plasma mem-
brane glucose transporters.
Vascular and glomerular glucose transporters may be in-
volved in a number of other physiologic and pathophysiologic
processes, such as the response to hypoxialischemia and the
regulation of matrix protein production. These areas remain to
be explored and their analysis will depend on a complete
understanding of glucose transporter regulation and function in
each cell type.
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